Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.36
Delayed Data
As of Jan 18
 -0.06 / -0.71%
Today’s Change
5.85
Today|||52-Week Range
11.34
-7.11%
Year-to-Date
Three Diabetes Clinical Trials to Watch in 2018
Jan 12 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close8.42
Today’s open8.41
Day’s range8.26 - 8.64
Volume33,347
Average volume (3 months)51,445
Market cap$120.1M
Data as of 3:59pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+9.20%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+283.15%
P/E ratioNM
Price/Sales46.88
Price/Book5.94

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...+0.15+4.52%
MTNBMatinas BioPharma Ho...-0.01-0.83%
--EcoGreen Internation...0.000.00%
CPIXCumberland Pharmaceu...0.000.00%
Data as of 8:00pm ET, 01/18/2018

Financials

Next reporting dateJanuary 31, 2018
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$2.5M
Annual profit (last year)-$10.5M
Net profit margin-426.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts